A connector is configured to electrically connect a plasma emitter array with an identification chip to a power supply controller, and to further mechanically support the emitter device supporting the array during use. Cooperating components of the connector and emitter device form a magnetic latch assembly: the connector includes one or more magnets flush with a top receiving surface of the connector, and one or more alignment pegs extending outward from the receiving surface; the emitter device includes a steel plate attached to a substrate, and one or more holes disposed through the plate and the substrate. The holes align with the alignment pegs and the magnets attract the plate and secure the emitter device against the top receiving surface. Electrical contacts of the connector establish electrical communication with the identification chip, providing power to the emitter device and enabling the controller to read data stored in the identification chip.

A medical assembly (100) includes a package (101) having an outer surface (102) with a major face (103) defining an aperture (701). An aperture-sealing label (702) selectively attaches to the outer surface to close the aperture and to be selectively peelable from the outer surface to expose the aperture. Five sheets (302,303,304,305,306) are arranged in a stacked configuration (309) within the package. Printed instructions (107) then define five steps (110,111,112,113,114) instructing when to use each sheet disposed within the package, and when to discard the each sheet disposed within the package, to clean a Foley catheter insertion site of either a male patient or a female patient, while reducing chances for causing a catheter associated urinary tract infection.

A medical assembly (100) includes a package (101) having an outer surface (102) with a major face (103) defining an aperture (701). An aperture-sealing label (702) selectively attaches to the outer surface to close the aperture and to be selectively peelable from the outer surface to expose the aperture. Five sheets (302,303,304,305,306) are arranged in a stacked configuration (309) within the package. Printed instructions (107) then define five steps (110,111,112,113,114) instructing when to use each sheet disposed within the package, and when to discard the each sheet disposed within the package, to clean a Foley catheter insertion site of either a male patient or a female patient, while reducing chances for causing a catheter associated urinary tract infection.

Provided herein is a surgical skin preparation device for applying an antiseptic composition to skin of a patient, including an applicator configured to absorb the antiseptic composition, the applicator having a top surface and a bottom surface, the bottom surface configured to apply the antiseptic composition to the skin of the patient and an indicator including a first layer of a first material configured to wick the antiseptic composition, the first material being opaque in a first state and transparent or translucent in a second state and a second layer of a non-wettable material, the second layer having at least one indicia that is visible to a user when the first layer is in the second state.

The invention relates to a flexible application aid for the treatment of wounds. The application aid can be used in particular for the debridement and/or cleansing of wounds, including the skin surrounding the wound. The application aid according to the invention including a flexible or elastically deformable application wand, facilitates debridement of superficial to deep wounds without the risk of injury to the wound.

The invention relates to a flexible application aid for the treatment of wounds. The application aid can be used in particular for the debridement and/or cleansing of wounds, including the skin surrounding the wound. The application aid according to the invention including a flexible or elastically deformable application wand, facilitates debridement of superficial to deep wounds without the risk of injury to the wound.

A patch having at least first and second parts is applied to the skin to prepare the skin for a transdermal device to be applied subsequently. The second part defines the area of the skin in which the required preparation process should be carried out, either by removal of a third part to form an opening in the second part or by providing preparation means such as microneedles on the underside of the second part. The second part is then removed to leave the first part adhered to the skin, which can be used as a guide for correctly locating the transdermal device so that the working area of the device and the prepared area of the skin are in alignment.

Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation can be provided. The exemplary apparatus and/or method can selectively kill and/or affect at least one virus. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 200 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range can be provided or which can be substantially harmful to cells of the body.

Porous devices are provided that include a particle-containing fibrous porous matrix and a fluid absorbed in the particle-containing porous fibrous nonwoven matrix. The particle-containing fibrous porous matrix includes a porous fibrous nonwoven matrix containing first polyolefin fibers, second polyolefin fibers including poly(ethylene), and fiberglass fibers; and microorganism-binding particles. The microorganism-binding particles are enmeshed in said porous fibrous nonwoven matrix. Methods of debridement are provided including providing a porous device including a particle-containing fibrous porous matrix and wiping a wound or an area of skin with the device; and providing a porous device including a porous fibrous nonwoven matrix and wiping a wound with the device. Further, kits are provided including a sterile package containing at least one porous device, and typically also instructions for debridement.

Porous devices are provided that include a particle-containing fibrous porous matrix and a fluid absorbed in the particle-containing porous fibrous nonwoven matrix. The particle-containing fibrous porous matrix includes a porous fibrous nonwoven matrix containing first polyolefin fibers, second polyolefin fibers including poly(ethylene), and fiberglass fibers; and microorganism-binding particles. The microorganism-binding particles are enmeshed in said porous fibrous nonwoven matrix. Methods of debridement are provided including providing a porous device including a particle-containing fibrous porous matrix and wiping a wound or an area of skin with the device; and providing a porous device including a porous fibrous nonwoven matrix and wiping a wound with the device. Further, kits are provided including a sterile package containing at least one porous device, and typically also instructions for debridement.